This website and all content is the property of Triumph Consultancy Services ltd. March 2013
Triumph have been heavily focused on the development of a capability to enable companies to implement or improve on their current RBM capability. As one of the key focus areas in the industry at the moment Triumph have observed a lot of talk and enthusiasm, but little in the way of tangible guidance.
Triumph are changing all that, and are excited to be in a position to offer the level of consultation and support needed to help ensure that this vital industry initiative is both accessible and executable for any company running clinical trials.
As members of the Metrics Champion Consortium (MCC) Triumph have developed a methodology to ensure that companies wishing to use the MMC or other metrics can truly get the accuracy and value they strive for from quality and performance metrics.....
NEWS & EVENTS
CLINICAL METRICS
Triumph offer a full range of services to support our clients
Triumph Consultancy Services was established in 2002, and has been focused in improving clinical trials through the application of innovative business process, technology and change solutions ever since. Triumph take a creative, pragmatic and results oriented approach to everything we do and are prepared to challenge the ‘business as usual’ approach which can be so prevalent in our industry . Our consultants have all come from the Pharma and CRO industries and understand the challenges faced from management, end user, and regulatory perspectives.
Our mission is simple, and with you we can make it a reality.
Our Mission:
To enhance the quality, experience and value of clinical trials
for both industry and patients
MAKING TRIALS BETTER, TOGETHER
Triumph offer a full range of products to support our clients 
OUR SERVICES
OUR PRODUCTS
FOLLOW US:
More Services
More Products
April 2013 - Triumph announce strategic partnership with Omnicom
Please go to the Events page to see the link to the press release.
March 2013 - New Case Study - Top 10 CRO Clinical Complicance and Performance
Please review the About Us page to see our latest case study.
Feb 2013 - Free Triumph presentations available to download
Triumph now publish downloadable presentations from each of our events and hosted webinars.
Find and follow us on SlideShare to see our current presentations available to view. Current presentation topics include Risk Based Monitoring, Metrics Based Approach to Clinical Trials and more.
Triumph have published a downloadable podcast on the Bio IT World website. The Podcast was developed in partnership with Medidata and explores Why virtual trial management has been waiting fore the cloud. See our Events page for more details
Free Webcast in partnership with Tibco Spotfire - 14th Feb
Adopting a metrics based approach for running clinical trials.
See our events page for more details
Linked In - First 100 Followers
Triumph are delighted to announce that our ongoing campaign to increase awareness of our products and services is bearing fruit. We have now got more than 100 industry professionals following our company on Linked In.
RISK BASED MONITORING
SUCCESS AT CLINTECH 2013!
Triumph are delighted to announce an incredibly successful Clintech 2013 event. The Future of CTMS survey was very well received by the audience and stimulated a lot of follow up conversations. We are in the process of publishing the results to those companies who completed the survey and will be posting the results publicly in a month’s time for those who didn’t.
Thank you to all the existing customers and new potential customers who came to visit us on our booth. We look forward to following up with you all shortly.
THE FUTURE OF CTMS - SURVEY RESULTS
During 1Q13, Triumph conducted an industry wide survey to understand how CTMS is currently being used, the function it performs, and how companies expect to evolve their use of CTMS over the next two years.
We are now happy to announce that the results are being made public domain and can be downloaded from Slide Share, by clicking the icon below.
Thank you to all the companies who responded to the survey and made the results so interesting and valuable.